Page 72 - SAMRC AnnualReport 2025-26
P. 72

Key Milestones and Achievements

            A major focus of the Unit has been the prevention of
            lower respiratory tract infections (LRTIs) to reduce
            child mortality, morbidity, and adverse long-term
            health outcomes. Findings from the 2025/2026
            period contributed to the development of new
            interventions to prevent paediatric illness.

            A key area of research has been RSV prevention
            in infants through maternal immunisation and
            long-acting monoclonal antibodies (RSV-LAmAb).
            Findings published in two separate articles in the
            New England Journal of Medicine (NEJM), with the       Laboratory Platforms.
            Unit Director as first author, demonstrated very high
            efficacy of RSV-LAmAb in preventing hospitalisation
            and  LRTIs  among  both  healthy  infants  and  those
            with underlying comorbidities. Updated analyses
            of maternal RSV immunisation also showed high
            efficacy,  particularly  against  severe  disease,  while
            providing reassuring safety data.
            Research from the DCHS has further demonstrated
            that  early-life  LRTIs  can  have  lasting  effects  on
            health by establishing developmental trajectories
            associated  with  impaired  lung  function.  In
            childhood  TB,  significant  progress  was  made  in
            improving diagnosis through biomarker-based
            molecular testing, evaluation of WHO treatment
            decision algorithms, and the development of
            artificial intelligence (AI) and imaging platforms for
            chest X-ray interpretation and point-of-care testing.  Infant Lung Function, Tidal Breathing.

            The Unit also continues to contribute  to several
            global analyses of disease burden, including RSV
            and influenza, as well as studies investigating risk
            factors and mechanisms of disease development
            through    transcriptomic,   epigenetic,   and
            inflammatory profiling.

            During the 2025/2026 reporting period, the
            Unit  published  peer-reviewed  scientific  articles,
            including several in high-impact journals, notably in
            NEJM and publications within The Lancet family of
            journals.

            Building Capacity Through
            Training, Mentorship, and Support

            The Unit's research activities have included substantial
            technology transfer, skills development, training, and   A major focus of the Unit has been the
            support for postgraduate students. Graduates and       prevention of lower respiratory tract infections
            trainees continue to make important contributions to   to reduce child mortality, morbidity, and
            child and maternal health across clinical, public health,   adverse longterm health outcomes.
            and laboratory science disciplines.



            70          SA M R C  A N N U A L R EP O R T 2 0 2 5 / 2 0 2 6
   67   68   69   70   71   72   73   74   75   76   77